“In 2005, I began dreaming about starting a trans-led, immigrant-led organization,” she says. “My dream came true two years later when I started the nonprofit.”
Anu Osinusi recently spoke with us about how hepatitis research and treatment have changed over her career, why HDV is considered the “forgotten virus” and what’s next for Gilead.
Triple-negative breast cancer tends to be among the most aggressive forms of breast cancer. But today, Ricki is healthy and working to eliminate racial disparities through Touch: The Black Breast Cancer Alliance, a current Gilead grantee.
Dwaun Warmack is the president of Claflin University in South Carolina, one of the nation’s top 10 Historically Black Colleges and Universities (HBCUs), where his longstanding commitment to social justice aligns with the university’s foundation.
Congratulations to Taiyin Yang, EVP, Pharmaceutical Development and Manufacturing, for being elected to the 2022 class of the National Academy of Engineering.
While as a company, we have unsurprisingly always taken a clear stance against stigma, Gilead has prioritized its grant-making to support organizations working at the community level in recent years.
Gilead has launched a first-of-its-kind educational partnership with historically Black colleges and universities (HBCUs) and Hispanic-Serving Institutions (HSIs).
Most people are familiar with the hepatitis B (HBV) and hepatitis C (HCV) viruses that attack the liver. But not many have heard of hepatitis D (HDV), the most severe form of viral hepatitis
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...